杂志简称：jci insight
中文译名：《临床研究杂志子刊机理解析》
收录属性：scie（2024版）, 目次收录（维普）, 目次收录（知网）,英文期刊,
自引率：1.30%
投稿方向：医学、medicine, research & experimental医学、研究与实验
SCI/E期刊基本信息
出版周期：半月刊 地区：美国
中科院分区：1区
是否TOP：TOP期刊
是否综述：非综述期刊
是否OA：非OA期刊
国际标准刊号：ISSNS2324-7703；EISSN2379-3708
杂志语言：英语
出版国家：美国
杂志官网 联系方式
出版地址：2015 MANCHESTER RD,ANN ARBOR,USA,MI,48104
杂志邮箱：
投稿网址：https://www.the-jci.org/controllers/UserAccountController.php
杂志官方网址：https://insight.jci.org/
出版商网址：
杂志投稿要求
投稿须知【杂志社官方网站信息】
Author information center
Revised October 4, 2021
Why submit your manuscript to JCI Insight?
Broad scope.
Basic and phase I/II clinical research articles in all biomedical specialties, including autoimmunity, gastroenterology, immunology, metabolism, neuroscience, oncology, pulmonology, vascular biology, and many others.
Open access.
All articles freely available from the moment of publication; and published in PubMed Central. See also License information.
Plan S compliance.
Meets cOAlition S requirements for authors who receive funding support from Plan S signatories; fully compliant with HHMI, Wellcome, and UK Research and Innovation (UKRI) open access policies.
Editorial Board.
The Editorial Board includes academic editors with a broad range of expertise who are active researchers in their fields.
ASCI legacy.
Self-published by the American Society for Clinical Investigation (ASCI), a nonprofit honor organization of physician-scientists established in 1908.
Impact Factor. 8.3 (2020).
JCI Insight considers research submissions in the following categories
Click the category name for formatting instructions; or go to How to submit your manuscript for the first time (new windows).
Research manuscripts provide substantial new mechanistic insights into biology and disease. These are complete descriptions of studies of scientific importance and broad interest to the JCI Insight readership.
Clinical Medicine manuscripts report new medical therapies, interventions, diagnostic advances, or observational studies in humans that have the potential to change medical practice. Reports of interest include clinical studies and observational analyses.
Resource and Technical Advance manuscripts introduce major databases and/or describe new research tools. Manuscripts reporting major databases should include new insights derived from the database and/or provide a rationale for why it provides a unique and valuable resource. Manuscripts reporting a new technological advance or model system should present evidence of an interesting biological insight, as well as demonstrating that the technology or model is an advance over the status quo. These articles are expected to have wide-ranging impact, enhance our understanding of disease, and spur future research in the field.
The Journal does not consider unsolicited manuscripts in non-research categories such as Review, Viewpoint, or Commentary. For more information, contact editors@insight.jci.org.
Contacting JCI Insight
Questions regarding manuscript handling and status should be addressed to staff@insight.jci.org. To avoid the possibility of misinterpretation and/or errors in communication, the Journal will typically communicate only with the corresponding author. For any communication with us, reference the assigned tracking number as noted in the Journal’s acknowledgment of your submission. If you do not have this information, provide the manuscript title and corresponding author’s name.
Questions concerning editorial policies or decisions should be addressed to the Science Editors at editors@insight.jci.org. Other members of the Editorial Board do not take calls or written inquiries from authors concerning decisions or other editorial matters. In general, responses are sent after evaluation of the written material and subsequent discussion by the Editorial Board.
Authors may submit inquiries to JCI Insight regarding manuscripts of potential suitability. Inquiries should include the manuscript abstract and a statement detailing the reasons why the manuscript might be of interest to the Journal’s readership. Decisions on such inquiries are not a substitute for peer review but are intended to provide informal guidance to authors in determining where to submit their research for full peer review.
Editorial policies and practices
Prior publication
Review of manuscripts
Confidentiality
Revisions, rejections, and rebuttals
Legal status of manuscripts
Reagent sharing
Data sets
Scientific integrity
Experimental design
Conflicts of interest
Prior publication
[Top of page] | [Editorial policies and practices]
JCI Insight does not consider research manuscripts that have been posted to a community preprint server to be prior publications.
Review of manuscripts
[Top of page] | [Editorial policies and practices]
The Science Editors assign manuscripts to appropriate Associate Editors. Papers may be rejected without external review if the Associate Editor, together with a Science Editor or the Editor in Chief, determines that the study does not significantly advance the field or the subject material is inappropriate for the JCI’s readership. When papers are sent for external review, the choice of reviewers is made by the Associate Editor and may include reviewers suggested by the authors during the submission process. Requests by authors to exclude specific potential reviewers will be honored to the greatest extent possible if a compelling reason is provided. At least two, and generally three, expert referees are asked to review the manuscript in a timely manner and to assign a priority based on content, originality, quality, relevance, and interest. Authors are informed of the final decision by email, with applicable comments from reviewers and Editors included.
Note: Manuscripts from the University of Michigan are handled not by the Editorial Board at large, but instead in a separate process; in these circumstances, a Science Editor is the only Editor privy to the manuscript and, if the manuscript is sent for review, works with an outside consultant to formulate a decision.
ASCI members. Any dues-paying ASCI member who is a corresponding author of a first-round submission, and whose dues are current, may designate up to 3 first-round JCI Insight submissions to be guaranteed for external peer review. A member wishing to designate a submission for guaranteed review must start the submission using the “JCI family of journals” portal through the member’s ASCI account. Manuscripts submitted using the guaranteed review must fit within the scope of the Journal and will be held to the same standard for publication as other manuscripts considered by the Editorial Board. Note that the guaranteed external review option may not be used for manuscripts, in the same form or after revision, that have previously been rejected by the Journal. If an option is used for a new submission that is identified as a revision of a previous manuscript, the option will be removed from the submission and become available for use on a new submission.
Reviewer rewards. Frequent reviewers are provided the opportunity to submit a new manuscript, as corresponding author, with a guarantee of external review. The Reviewer Reward is granted in January to reviewers who have completed on-time reviews for at least 3 separate manuscripts within the preceding 18 months. Only 1 reward may be used per calendar year. Submissions using the reward must fit within the scope of the journal and will be held to the same standard for publication as other manuscripts considered by the Editorial Board. Note: ASCI members whose dues are current receive a separate benefit for guaranteed external review (see above) and may not earn Reviewer Rewards in addition. More details are available here.
Confidentiality
[Top of page] | [Editorial policies and practices]
The peer review process rests on the assumption that an assigned reviewer will treat all manuscripts as privileged information. A reviewer may request advice from another party, subject to the general principle of confidentiality and notification of JCI Insight.